Published in Gastroenterology on June 01, 1997
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45
Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice. Dig Dis Sci (2005) 1.12
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis. Ann Rheum Dis (2004) 0.94
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf (2009) 0.94
Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy). J Gastroenterol (2007) 0.86
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk. Pain Pract (2013) 0.84
Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci (2001) 0.83
Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions. Postgrad Med J (2001) 0.82
Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? Int J Clin Pract (2006) 0.79
Clinical evidence of interaction between clopidogrel and proton pump inhibitors. World J Cardiol (2011) 0.79
High-dose famotidine for prevention of NSAID ulcers? Gastroenterology (1997) 0.78
The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther (2013) 0.76
The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy. Can J Gastroenterol (2010) 0.75
A study of the changes in the cause of peptic ulcer bleeding. World J Gastrointest Endosc (2012) 0.75
[Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs]. Wien Med Wochenschr (2003) 0.75
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99
Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. BMJ (1992) 4.32
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med (1992) 4.27
Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med (1997) 4.03
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med (1998) 3.96
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology (1985) 3.12
The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med (1996) 2.99
Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis (1988) 2.46
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ (1990) 2.25
Self-medication of antibacterials without prescription (also called 'over-the-counter' use). A report of a Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (1999) 2.23
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12
Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis (2002) 2.11
Oro-facial granulomatosis--a clinical and pathological analysis. Q J Med (1985) 2.11
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet (1993) 2.10
Changes in keratan sulphate levels in the serum of a long distance runner. Br J Rheumatol (1990) 2.03
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ (1994) 1.99
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Prescribing in the UK. Lancet (2001) 1.93
Journals should see original protocols for clinical trials. BMJ (2001) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med (1996) 1.85
A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology (Oxford) (2001) 1.80
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs (1998) 1.74
Differential diagnosis of calf pain with musculoskeletal ultrasound imaging. Ann Rheum Dis (2004) 1.73
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol (1997) 1.70
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int (1987) 1.62
Spondylometry in a normal population and in ankylosing spondylitis. Rheumatol Rehabil (1973) 1.60
A study of the role of bile acids in the pathogenesis of postvagotomy diarrhoea. Gut (1973) 1.58
Poncet's disease--fact or fiction? A re-appraisal of tuberculous rheumatism. Tubercle (1974) 1.58
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut (1991) 1.58
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut (1988) 1.54
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond) (1992) 1.53
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res (1994) 1.49
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.48
Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease. J Clin Pathol (1997) 1.45
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy (2010) 1.44
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am J Physiol (1999) 1.42
A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology (1997) 1.42
Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs. Ann Rheum Dis (1976) 1.42
Ileo-caecal ulceration associated with the use of diclofenac slow release. Aliment Pharmacol Ther (1993) 1.40
Two sisters with ANCA positive vasculitis. Ann Rheum Dis (1993) 1.40
Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun (1992) 1.39
Magnesium deficiency in patients on home enteral nutrition. Clin Nutr (1990) 1.39
Neodymium yttrium aluminium garnet laser photocoagulation for major haemorrhage from peptic ulcers and single vessels: a single blind controlled study. Br Med J (Clin Res Ed) (1983) 1.39
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Non-steroidal drug-induced peptic ulceration can we really protect the stomach? Br J Rheumatol (1992) 1.39
Somatostatin in treatment of haematemesis and melaena. Lancet (1985) 1.39
The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature. J Med Genet (1976) 1.38
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Prostaglandins and ulcerative colitis. Gut (1984) 1.36
Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis (2003) 1.35
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther (2002) 1.35
The aesthetics of colour. Perception (1982) 1.34
An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34
Inhibition of prostaglandin synthetase in human rectal mucosa. Gut (1983) 1.32
Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut (1993) 1.32
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther (2005) 1.32
Intravenous omeprazole rapidly raises intragastric pH. Gut (1985) 1.31
The gold plated stomach? Ann Rheum Dis (1993) 1.30
High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy (2011) 1.30
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut (1992) 1.30
Collagenous colitis: possible response to sulfasalazine and local steroid therapy. Gastroenterology (1985) 1.30
Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J Clin Microbiol (1999) 1.28
Autonomic neuropathy in rheumatoid arthritis. Br Med J (1979) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27
Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. Gut (1986) 1.27
The evaluation of antirheumatic drugs. Curr Med Res Opin (1973) 1.26
Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther (2007) 1.25
Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut (1993) 1.24
Persistence of Staphylococcus aureus as detected by polymerase chain reaction in the synovial fluid of a patient with septic arthritis. Br J Rheumatol (1997) 1.24
Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. Endoscopy (2008) 1.24
Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis. Ann Rheum Dis (1974) 1.23
Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination. Curr Microbiol (1999) 1.23
The effect of the hypermobility syndrome on knee joint proprioception. Br J Rheumatol (1995) 1.21
A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol (1984) 1.21
Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. Gut (1983) 1.21
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21
Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut (1998) 1.20
Home enteral tube feeding with a liquid diet in the long term management of inflammatory bowel disease and intestinal failure. Scott Med J (1980) 1.20
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ (1989) 1.18
Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease. Br Med J (Clin Res Ed) (1988) 1.17